Results of the EICESS-92 study: Two randomized trials of Ewing's sarcoma treatment - Cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients

Michael Paulussen*, Alan W. Craft, Ian Lewis, Allan Hackshaw, Carolyn Douglas, Jürgen Dunst, Andreas Schuck, Winfried Winkelmann, Gabriele Köhler, Christopher Poremba, Andreas Zoubek, Ruth Ladenstein, Henk Van Den Berg, Andrea Hunold, Anna Cassoni, David Spooner, Robert Grimer, Jeremy Whelan, Anne McTiernan, Herbert Jürgens

*Korrespondierende/r Autor/-in für diese Arbeit
168 Zitate (Scopus)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Results of the EICESS-92 study: Two randomized trials of Ewing's sarcoma treatment - Cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients“. Zusammen bilden sie einen einzigartigen Fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience